|
James E. Muller, M.D. is an American cardiologist and medical device executive. He was a member of the faculty of Harvard Medical School for over 25 years, where he studied triggers of coronary artery plaque rupture and sudden cardiac death. He is believed to have coined the term “vulnerable plaque” to denote the plaques at high likelihood of rupture and causation of coronary thrombosis. He co-founded International Physicians for the Prevention of Nuclear War.〔http://query.nytimes.com/gst/fullpage.html?sec=health&res=9805EED91639F932A35757C0A9659C8B63〕 He is a co-recipient of the 1985 Nobel Peace Prize through International Physicians for the Prevention of Nuclear War.〔http://query.nytimes.com/gst/fullpage.html?sec=health&res=9805EED91639F932A35757C0A9659C8B63〕 He is Founder, Chief Medical Officer, and Chairman of the Board〔http://www.infraredx.com/wt/page/jmuller〕 of InfraReDx, Inc. which manufactures a catheter-based near-infrared spectroscopy system used to identify cholesterol rich plaques in patients undergoing cardiac catheterization. This system was cleared by the U.S. Food and Drug Administration 〔http://www.fda.gov/bbs/topics/NEWS/2008/NEW01827.html〕 for use to identify lipid core in coronary plaques of interest. ==References== 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「James E. Muller」の詳細全文を読む スポンサード リンク
|